Amgen AMGN
NASDAQ AMGN
$439.26 -8.02 (-1.79%)
At close: Oct 23, 2026 · 4:00 PM EDT

Amgen (AMGN) Long-Term Investments (2013 - 2014)

Updated

Amgen (AMGN) posted Long-Term Investments of $3.41 billion for Q1 2014, up 0.1% from the prior quarter.

Analysis

Amgen (AMGN) Long-Term Investments (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn 3.86 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn -
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn 266.00 Mn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.22 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 69.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn 297.00 Mn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn -
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 1.56 Bn
10 Vertex Pharmaceuticals 132.74 Bn 104.74 Bn 2.84 Bn 5.79 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2014 3.41 Bn
Dec 31, 2013 3.41 Bn
Sep 30, 2013 3.41 Bn
API Access

Amgen Long-Term Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-investments&ticker=AMGN&period=max&api_key=YOUR_API_KEY